For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of INVO Bioscience Inc (NASDAQ: INVO) closed at $1.30 in the last session, up 4.84% from day before closing price of $1.24. In other words, the price has increased by $4.84 from its previous closing price. On the day, 0.61 million shares were traded. INVO stock price reached its highest trading level at $1.46 during the session, while it also had its lowest trading level at $1.2.
Ratios:
We take a closer look at INVO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.12 and its Current Ratio is at 0.15. In the meantime, Its Debt-to-Equity ratio is 18.18 whereas as Long-Term Debt/Eq ratio is at 13.24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INVO now has a Market Capitalization of 3565938 and an Enterprise Value of 17852496. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.18. Its current Enterprise Value per Revenue stands at 5.91 whereas that against EBITDA is -2.719.
Stock Price History:
Over the past 52 weeks, INVO has reached a high of $10.50, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 24.89%, while the 200-Day Moving Average is calculated to be -10.20%.
Shares Statistics:
According to the various share statistics, INVO traded on average about 3.80M shares per day over the past 3-months and 23854570 shares per day over the past 10 days. A total of 2.74M shares are outstanding, with a floating share count of 2.72M. Insiders hold about 0.96% of the company’s shares, while institutions hold 4.12% stake in the company. Shares short for INVO as of 1711584000 were 12058 with a Short Ratio of 0.00, compared to 1709164800 on 11160. Therefore, it implies a Short% of Shares Outstanding of 12058 and a Short% of Float of 0.45999999999999996.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.23. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $20.97M in the next fiscal year. The high estimate is $20.97M and the low estimate is $20.97M.
